Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2009) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 |  |
| 2 | Expert Opinion on Therapeutic Targets | journal | 1.469 Q1 | 106 | 116 | 345 | 11796 | 1225 | 321 | 3.82 | 101.69 | |
| 3 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.951 Q2 | 100 | 125 | 259 | 11138 | 976 | 253 | 3.57 | 89.10 | |
| 4 | Issues in Toxicology | book series | 0.197 Q3 | 18 | 18 | 51 | 1596 | 15 | 47 | 0.29 | 88.67 | |
| 5 | Expert Opinion on Therapeutic Patents | journal | 0.477 Q3 | 88 | 109 | 332 | 9508 | 405 | 321 | 1.21 | 87.23 | |
| 6 | Expert Opinion on Biological Therapy | journal | 1.137 Q1 | 102 | 141 | 454 | 11591 | 1569 | 448 | 3.57 | 82.21 | |
| 7 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | |
| 8 | Expert Opinion on Pharmacotherapy | journal | 0.613 Q2 | 93 | 271 | 794 | 20462 | 1915 | 773 | 2.52 | 75.51 | |
| 9 | Expert Opinion on Investigational Drugs | journal | 1.251 Q1 | 117 | 165 | 481 | 12080 | 1956 | 449 | 4.54 | 73.21 | |
| 10 | Current Opinion in Investigational Drugs | journal | 1.276 Q1 | 83 | 136 | 371 | 9871 | 1308 | 339 | 3.66 | 72.58 | |
| 11 | Expert Review of Vaccines | journal | 1.278 Q1 | 105 | 156 | 310 | 11295 | 1142 | 276 | 3.97 | 72.40 | |
| 12 | Future Medicinal Chemistry | journal | 90 | 120 | 0 | 8645 | 0 | 0 | 0.00 | 72.04 | | |
| 13 | Clinical Pharmacokinetics | journal | 1.494 Q1 | 184 | 60 | 212 | 4237 | 1153 | 202 | 5.36 | 70.62 | |
| 14 | Molecular Diagnosis and Therapy | journal | 0.754 Q2 | 68 | 34 | 123 | 2398 | 314 | 117 | 2.54 | 70.53 | |
| 15 | Current Opinion in Molecular Therapeutics | journal | 1.249 Q1 | 67 | 77 | 212 | 5421 | 730 | 194 | 3.72 | 70.40 | |
| 16 | Current Opinion in Drug Discovery and Development | journal | 1.722 Q1 | 85 | 73 | 215 | 5063 | 1028 | 197 | 5.07 | 69.36 | |
| 17 | Trends in Pharmacological Sciences | journal | 5.016 Q1 | 244 | 81 | 283 | 5573 | 2791 | 267 | 9.25 | 68.80 | |
| 18 | Therapeutic Advances in Neurological Disorders | journal | 0.110 Q4 | 68 | 33 | 18 | 2252 | 9 | 13 | 0.50 | 68.24 | |
| 19 | Neuropsychopharmacology | journal | 3.590 Q1 | 249 | 255 | 835 | 16245 | 5588 | 800 | 6.85 | 63.71 | |
| 20 | HIV Therapy | journal | 14 | 60 | 0 | 3725 | 0 | 0 | 0.00 | 62.08 | | |
| 21 | Neuropharmacology | journal | 1.807 Q1 | 191 | 250 | 800 | 15008 | 3134 | 797 | 4.08 | 60.03 | |
| 22 | CNS Neuroscience and Therapeutics | journal | 0.839 Q2 | 91 | 35 | 31 | 2080 | 84 | 30 | 2.71 | 59.43 | |
| 23 | Autonomic and Autacoid Pharmacology | journal | 0.319 Q3 | 24 | 17 | 103 | 935 | 87 | 102 | 1.03 | 55.00 | |
| 24 | Drug Discovery Today | journal | 1.979 Q1 | 215 | 154 | 459 | 8116 | 2858 | 433 | 6.23 | 52.70 | |
| 25 | Antiviral Chemistry and Chemotherapy | journal | 0.530 Q3 | 59 | 17 | 79 | 891 | 154 | 77 | 2.12 | 52.41 | |
| 26 | Drug Safety | journal | 1.384 Q1 | 140 | 99 | 305 | 5046 | 1257 | 257 | 3.88 | 50.97 | |
| 27 | Pharmacogenomics | journal | 1.051 Q2 | 100 | 184 | 468 | 8961 | 1614 | 412 | 3.35 | 48.70 | |
| 28 | International Journal of Neuropsychopharmacology | journal | 1.897 Q1 | 125 | 136 | 294 | 6496 | 1149 | 263 | 4.07 | 47.76 | |
| 29 | Chinese Medicine | journal | 0.617 Q2 | 56 | 24 | 34 | 1143 | 91 | 32 | 2.40 | 47.63 | |
| 30 | Cardiovascular Therapeutics | journal | 0.927 Q2 | 54 | 37 | 32 | 1698 | 93 | 28 | 2.91 | 45.89 | |
| 31 | Pharmacogenomics Journal | journal | 1.676 Q1 | 95 | 44 | 146 | 1939 | 760 | 145 | 4.92 | 44.07 | |
| 32 | Fundamental and Clinical Pharmacology | journal | 0.707 Q2 | 85 | 90 | 228 | 3924 | 546 | 222 | 2.37 | 43.60 | |
| 33 | ChemMedChem | journal | 1.205 | 119 | 218 | 530 | 9458 | 1780 | 522 | 3.35 | 43.39 | |
| 34 | Journal of Immune Based Therapies and Vaccines | journal | 0.419 Q3 | 21 | 5 | 26 | 216 | 39 | 26 | 1.79 | 43.20 | |
| 35 | Clinical and Experimental Pharmacology and Physiology | journal | 0.873 Q2 | 115 | 199 | 712 | 8256 | 1723 | 691 | 2.10 | 41.49 | |
| 36 | Acta Pharmacologica Sinica | journal | 0.624 Q2 | 117 | 199 | 659 | 8200 | 1233 | 657 | 1.81 | 41.21 | |
| 37 | Journal of Psychopharmacology | journal | 1.378 Q1 | 135 | 128 | 394 | 5266 | 1272 | 343 | 2.82 | 41.14 | |
| 38 | Drug Discovery Today: Therapeutic Strategies | journal | 0.300 Q3 | 31 | 22 | 165 | 901 | 124 | 150 | 0.46 | 40.95 | |
| 39 | Journal of Pharmacy and Pharmacology | journal | 0.618 Q2 | 137 | 208 | 616 | 8460 | 1286 | 608 | 1.99 | 40.67 | |
| 40 | PharmacoEconomics | journal | 1.186 Q1 | 118 | 90 | 305 | 3575 | 816 | 244 | 2.63 | 39.72 | |
| 41 | Mathematical Medicine and Biology | journal | 0.620 Q2 | 49 | 26 | 62 | 1023 | 105 | 61 | 1.26 | 39.35 | |
| 42 | Journal of Peptide Science | journal | 0.659 Q2 | 73 | 111 | 374 | 4337 | 632 | 364 | 1.78 | 39.07 | |
| 43 | Immunopharmacology and Immunotoxicology | journal | 0.321 Q3 | 61 | 97 | 170 | 3706 | 177 | 169 | 0.89 | 38.21 | |
| 44 | Antiviral Therapy | journal | 1.619 Q1 | 93 | 134 | 418 | 4995 | 1651 | 411 | 4.07 | 37.28 | |
| 45 | Nature Reviews Drug Discovery | journal | 6.955 Q1 | 391 | 196 | 485 | 7293 | 6011 | 387 | 11.47 | 37.21 | |
| 46 | Chemical Biology and Drug Design | journal | 0.964 | 91 | 148 | 336 | 5442 | 900 | 325 | 2.52 | 36.77 | |
| 47 | Xenobiotica | journal | 0.865 Q2 | 89 | 100 | 252 | 3638 | 745 | 249 | 3.07 | 36.38 | |
| 48 | Personalized Medicine | journal | 0.222 Q3 | 36 | 69 | 173 | 2470 | 107 | 146 | 0.67 | 35.80 | |
| 49 | BMC Clinical Pharmacology | journal | 0.599 Q2 | 43 | 19 | 34 | 679 | 84 | 34 | 2.46 | 35.74 | |
| 50 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.848 Q2 | 57 | 38 | 98 | 1324 | 219 | 94 | 2.27 | 34.84 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data